vancomycin has been researched along with meropenem in 234 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.43) | 18.7374 |
| 1990's | 6 (2.56) | 18.2507 |
| 2000's | 46 (19.66) | 29.6817 |
| 2010's | 105 (44.87) | 24.3611 |
| 2020's | 76 (32.48) | 2.80 |
| Authors | Studies |
|---|---|
| Fiett, J; Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Izdebski, R; Sadowy, E | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
| Abbanat, D; Bush, K; Fernandez, J; Flamm, RK; Hilliard, JJ; Melton, JL; Santoro, CM; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F | 1 |
| Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
| Banerjee, A; Chakrapani, H; Lahiri, S; Malwal, SR; Pardeshi, KA; Rangarajan, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Bai, PY; Chu, WC; Cui, DY; Hua, YG; Liu, HM; Liu, Q; Qin, S; Yin, HY; Zhang, E; Zhang, YJ | 1 |
| Bai, PY; Chu, WC; Cui, DY; Hua, YG; Qin, S; Yang, QQ; Yang, Y; Yang, ZQ; Zhang, E | 1 |
| Bai, PY; Chu, WC; Cui, DY; Hua, YG; Qin, SS; Yang, QQ; Yang, Y; Zhang, E | 1 |
| Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
| Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
| Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
| Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Arhema Frejat, FO; Cao, Y; Kong, X; Liu, H; Luo, C; Ren, C; Shi, X; Wang, H; Wu, C; Yang, P; Yang, Y; Zhai, H; Zhang, S | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Andrews, JM; Ashby, JP; Wise, R | 1 |
| Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
| Akram, S; Campos, JM; Donkersloot, JA; Keith, JM; Pikis, A; Rodriguez, WJ | 1 |
| Kimpara, I; Kudo, E; Kudo, H; Kudo, Y; Miura, T; Saitoh, Y; Sato, S; Tsujino, M | 1 |
| Tuohy, M; Washington, JA | 1 |
| Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Cottagnoud, M; Cottagnoud, P; Gerber, CM; Neftel, KA; Täuber, MG | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Bettington, H; Goldsmith, DJ; Pattison, JM; Sheerin, N; Tahir, H; Thomas, G | 1 |
| Brade, V; Hunfeld, KP; Kekoukh, E; Kraiczy, P; Weigand, J; Wichelhaus, TA | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Colaert, J; Devlieger, H; Van Caster, A; Vandecasteele, SJ; Verhaegen, J | 1 |
| Chamberlain, AJ; Wojnarowska, F | 1 |
| Avila-Agüero, ML; Huertas, E; Ulloa-Gutierrez, R | 1 |
| Sakata, H | 1 |
| Berger, C; Kindli, K; Nadal, D; Niggli, FK | 1 |
| Claesson, MH; Gad, M; Kristensen, NN; Møller, PL; Paerregaard, A | 1 |
| Bode-Böger, SM; Czock, D; Fliser, D; Hafer, C; Keller, F; Kielstein, JT; Kuse, E; Schöpke, T | 1 |
| Dager, WE | 1 |
| Lin, SF; Yang, WC | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Baleani, M; Guandalini, L; Persson, C; Tigani, D; Viceconti, M | 1 |
| Arima, H; Hoshitani, K; Ikeda, N; Kobayashi, K; Nakamoto, H; Okada, H; Okada, S; Shoda, J; Sugahara, S; Suzuki, H; Takane, Y; Uchida, K | 1 |
| Kitiyakara, C; Likittanasombat, K; Lothuvachai, T; Milindankura, S; Sakulsaengprapha, A | 1 |
| Dehority, W; Khosravi, A; Nizet, V; Uchiyama, S | 1 |
| Karabay, O; Koçoğlu, E | 1 |
| Chan, TM; Lai, KN; Tang, SC; Tse, KC | 1 |
| Tobias, JD | 1 |
| Ferrieri, P; Harker-Murray, P; Lee, AB; Schleiss, MR; Tolar, J | 1 |
| Andollina, A; Bertoni, F; Bertoni, G; Maria Borrelli, A; Tigani, D; Trentani, F; Trentani, P; Zolezzi, C | 1 |
| Behra, A; Dutta, U; Iyer, VH; Kochhar, R; Nagi, B; Rana, SS; Singh, K; Singh, P | 1 |
| Andollina, A; Baleani, M; Borrelli, AM; Persson, C; Tigani, D; Zolezzi, C | 1 |
| Dehority, W; Leake, JA | 1 |
| Armonda, RA; Baraniak, SM; Brett-Major, DM; Christensen, RL; Ganesan, A; Gilhooly, JE; Grant, GT | 1 |
| Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
| Abubaker, J; Khan, SG; Khursheed, M; Noman, F; Noor, SA | 1 |
| Akizuki, T; Watanabe, Y | 1 |
| Hong, KH; Kim, EC; Park, JS | 1 |
| Cabellos, C; Doménech, A; Force, E; Gudiol, F; Ribes, S; Taberner, F; Tubau, F; Viladrich, PF | 1 |
| Almafragi, A; Dujardin, K; Vandorpe, J | 1 |
| Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E | 1 |
| Aksoy, A; Bahat, E; Cakir, M; Dilber, B; Dilber, E; Kamaşak, T | 1 |
| Mizrak, B; Ozgen, U; Saraç, K; Uzüm, I | 1 |
| Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y | 1 |
| Ballard, SA; Grabsch, EA; Grayson, ML; Howden, BP; Johnson, PD; Seemann, T; Stinear, TP; Young, HL | 1 |
| Asano, Y; Hashido, H; Kawamoto, H; Matsubara, S; Matsukawa, Y; Mikamo, H; Mitsuyama, J; Miyabe, T; Nomura, N; Sawamura, H; Suematsu, H; Teraji, M; Watanabe, K; Yamaoka, K | 1 |
| Habermann, C; Hahne, JD; Peitsmeyer, P | 1 |
| Fasanello, J; Hereth, J; Sharp, JK | 1 |
| Inamasu, J; Kuramae, T; Nakatsukasa, M; Tomiyasu, K | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Arzoglou, V; D'Angelo, L; Di Rocco, C; Koutzoglou, M | 1 |
| Lamartina, C; Petruzzi, M | 1 |
| Cheng, AC; Huysmans, M; Peel, T; Spelman, D; Spelman, T | 1 |
| Kimura, Y; Komatsu, T; Sudo, M | 1 |
| Dilmen, U; Erdeve, O; Kılıç, S; Kızılelma, A; Oğuz, SS; Saygan, S; Zergeroğlu, S | 1 |
| Amann, K; Bröcker, EB; Müller, PA; Trautmann, A | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Mikamo, H; Yamagishi, Y | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL | 1 |
| Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS | 1 |
| Alam, MJ; Arora, V; Garey, KW; Singh, V | 1 |
| Davis, JL; Flynn, HW; Rachitskaya, AV | 1 |
| Giebaly, DE; Horriat, S; Mangaleshkar, S; Sinha, A | 1 |
| Domville-Lewis, C; Friedland, PL; Santa Maria, PL | 1 |
| Lipman, J; Lonsdale, DO; Roberts, JA; Udy, AA | 1 |
| Alley, M; Flaherty, M; Lisella, J; Papaliodis, D; Rosenbaum, A | 1 |
| Eisenbach, C; Mischnik, A; Sandig, C; Steinebrunner, N; Stremmel, W; Zimmermann, S | 1 |
| Matsue, K; Nishida, Y; Sugihara, H; Takeuchi, M; Ugai, T; Yamakura, M | 1 |
| Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
| Cheng, J; Li, X; Shao, Y; Xie, QX | 1 |
| Chow, KM; Kwan, BC; Lee, KP; Leung, CB; Li, PK; Ma, TK; Szeto, CC | 1 |
| Jamal, JA; Lipman, J; Roberts, JA; Udy, AA | 1 |
| Ferrara, S; Gambino, A; Martines, F; Mucia, M; Salvago, P; Sireci, F | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Kees, MG; Kloft, C; Kuss, J; Wicha, SG | 1 |
| Akin, IM; Arsan, S; Atasay, B; Ciftci, E; Ince, E; Okulu, E | 1 |
| Abraham, T; Casselman, J; Hostoffer, R; Kim, YM; Saad, A; Tcheurekdjian, H; Toller-Artis, E; Wessell, KR | 1 |
| Deshpande, GA; Hiraoka, E; Kitazono, H; Odani, N | 1 |
| Beader, N; Bedenić, B; Ćačić, M; Godič-Torkar, K; Mihaljević, L; Prahin, E; Vraneš, J | 1 |
| Gao, Z; Hao, S; Hou, Z; Liu, B; Tian, R | 1 |
| Barbara, CS; Caresta, E; Ceccarelli, G; D'Abramo, A; d'Ettorre, G; Mascellino, MT; Moretti, C; Oliva, A; Papoff, P; Venditti, M; Visca, P; Vullo, V | 1 |
| Alby, K; Han, JH; Mills, JP; Talati, NJ | 1 |
| Bahl, MI; Frost, M; Hansen, T; Holst, JJ; Jensen, US; Knop, FK; Licht, TR; Mikkelsen, KH; Pedersen, O; Rehfeld, JF; Rosenberg, J; Vilsbøll, T | 1 |
| Bravo-Molina, A; Hernández-Quero, J; Linares-Palomino, JP; Lozano-Alonso, S; Ros-Díe, E; Vera-Arroyo, B | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| Bao, Y; Mo, Y; Qi, S; Qiu, B; Zeng, H; Zhang, N | 1 |
| Cohen, H; Peyko, V; Smalley, S | 1 |
| Hamada, Y; Monogue, ML; Nicolau, DP; Thabit, AK | 1 |
| Jahangiri, F; Sayyahfar, S; Zarei, E | 1 |
| Kloft, C; Wicha, SG | 1 |
| Bae, S; Choi, SH; Chong, YP; Kim, HS; Kim, MC; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Park, SJ; Sung, H; Woo, JH | 1 |
| Agostoni, C; Esposito, S; Lucchi, T; Pinzani, R; Principi, N; Raffaeli, G | 1 |
| Ali, I; Fawad, S; Khalid, L; Khan, AU; Wahid, K | 1 |
| Matsuda, Y; Sakaida, H; Takeuchi, K | 1 |
| Huisinga, W; Kloft, C; Wicha, SG | 1 |
| Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
| Bo, H; Hui-Min, Y; Lin Liu, Y; Shamsi, BH; Xu-Chun, M; Yan-Ping, W | 1 |
| DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
| Hanson, J; Reeves, B; Smith, S; Tacon, C; Wiseman, G; Young, A | 1 |
| Allfather, P; Nagler, J | 1 |
| Bartel, BJ; Catlin, JS; Gilder, RE; Kramer, CJ; Mullins, BP | 1 |
| Cai, Y; Gan, Y; Sun, Y; Tang, J; Yu, C | 1 |
| Arıcı, M; Balcı, C; Hayran, SA; Ünal, S; Uzun, Ö; Yüce, D | 1 |
| Angele, M; Bauer, A; Guba, M; Hinske, LC; Kinzinger, J; Pratschke, S; Scheiermann, P; Siebers, C; Weig, T; Zoller, M | 1 |
| Burgess, DS; Rutter, WC | 1 |
| Haldar, J; Manjunath, GB; Mitra, SD; Paramanandham, K; Samaddar, S; Sarkar, P; Shome, BR; Yarlagadda, V | 1 |
| Decousser, JW; Dowzicky, MJ; Fines-Guyon, M; Soussy, CJ; Woerther, PL | 1 |
| Eminoğlu, EM; Hocaoğlu, M; Karateke, A; Turgut, A; Yılmaz Karadağ, F | 1 |
| Kolakshyapati, M; Li, M; Lou, L; Shi, LF; Shrestha, T; Wang, Z; Yang, KC; Zhou, J | 1 |
| Jia, XL; Pathak, JL; Su, JM; Tong, JF | 1 |
| Keller, F | 1 |
| Campos, M; Canovas-Segura, B; Juarez, JM; Marin, R; Morales, A; Palacios, F | 1 |
| Beader, N; Bedenić, B; Benčić, A; Čačić, M; Car, H; Lukić-Grlić, A; Šijak, D; Slačanac, D; Sviben, M; Tripković, M | 1 |
| An, G; Creech, B; Fissell, WH; Groszek, JJ; Marsh, E; Patel, P; Shotwell, M; Verhoven, SM | 1 |
| Brinsley, J; Farooque, S; Nicholson, P; Wakelin, S | 1 |
| Barreto, EF; Kashani, KB; Mara, KC; Nelson, S; Personett, HA; Rule, AD; Sakhuja, A; Schreier, DJ; Steckelberg, JM; Tande, AJ; Tootooni, MS | 1 |
| Janković, SM | 1 |
| Nielsen, SY; Nørskov-Lauritsen, N | 1 |
| Hait, V; Lisonkova, S; Ng, K; Osiovich, H; Paquette, V; Roberts, A; Shivanada, S; Tilley, P; Ting, JY | 1 |
| Al Zaibag, M; Aljohany, SM; Alothman, AF; Arabi, YM; Baharoon, S; Balkhy, HH; El-Metwally, A; El-Saed, A | 1 |
| Garcia-Carretero, R | 1 |
| Ghodsi, M; Izadi, A; Khedmat, L; Kianfar, S; Mojtahedi, SY; Rahbarimanesh, A; Sadeghi, P; Siyahkali, SJM; Yazdi, MK | 1 |
| Cheng, H; Cheng, XL; Dong, YL; Dong, YZ; Li, Y; Wang, AM; Zhang, T; Zhang, Y | 1 |
| Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S | 1 |
| Hasegawa, M; Hatachi, T; Inata, Y; Ito, Y; Iwai, S; Kugo, Y; Shimizu, Y; Sofue, T; Takeuchi, M; Yamauchi, S | 1 |
| Aiyappa, G; Andrade, SJ; Lewis, LE; Purkayastha, J; Raj K, A | 1 |
| Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
| AlAnazi, L; AlFudail, S; AlMarzouq, F; Hakeam, HA; Mansour, R | 1 |
| Adams, SM; Babbitt, CJ; Morphew, T; Ngo, L | 1 |
| Hua, W; Huang, HQ; Li, N; Shen, HH; Zhang, GS | 1 |
| Anada, R; Dougu, N; Hayashi, T; Konishi, H; Nakatsuji, Y; Nukui, T | 1 |
| Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
| Ide, N; Sato, S; Sawaguchi, K | 1 |
| Chai, W; Chen, JY; Jia, CQ; Kuo, FC; Xu, C; Zhang, MH | 1 |
| Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
| Costa, TXD; Leopoldino, RWD; Martins, RR; Nascimento, ARFD; Santos, METD | 1 |
| Abraham, M; Behmer Hansen, R; Gold, J; Lad, M; Mammis, A; Zhao, K | 1 |
| Cheung, BMY; Qi, Z; Qin, X; Tsoi, MF; Zhang, L; Zhao, X | 1 |
| Kächele, M; Keller, F | 1 |
| Cavani Jorge Santos, SR; Chaves, L; Levin, AS; Macedo, E; Machado, AS; Mendes, ET; Oliveira, MS; Perdigão Neto, LV; Sanches, C; Vieira da Silva, C | 1 |
| Bannan, A; Diab, J; Pollitt, T | 1 |
| Hay, K; Lavana, J; McNamara, JF; O'Callaghan, K | 1 |
| Abolghasemi, S; Mardani, M; Shabani, S | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Grabein, B; Liebchen, U; Paal, M; Scharf, C; Schroeder, I; Siebers, C; Zander, J; Zoller, M | 1 |
| Abe, T; Hirata, K; Morikawa, K; Nozaki, M; Wada, K; Yanagihara, I | 1 |
| Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
| Egge, JA; Heintz, BH; Lee, JD; Livorsi, DJ; Lund, BC; Mosher, HJ | 1 |
| Alex, A; Lepcha, A; Mammen, MD; Paulose, AA; Philip, A | 1 |
| Huntul, MA; Kabli, NA; Thabit, AK; Tookhi, RF | 1 |
| Damon, L; DeVoe, C; Doernberg, SB; Dzundza, JH; Graff, LR; Griffith, LM; Gu, TM; Hampton, SR; Hilts-Horeczko, A; Macapinlac, BAC; Olin, R; Rodriguez-Monguio, R; Shenoy, S; Strnad, L; Trinh, TD; Wang, L; Yang, K | 1 |
| Fang, X; Xuan, J; Yang, Y; Yao, J; Zhang, Q | 1 |
| Heskamp, B; Körtge, A; Majcher-Peszynska, J; Mitzner, S; Wasserkort, R | 1 |
| Booncharoen, S; Chaiyapoke, C; Chanawong, A; Lulitanond, A; Srisrattakarn, A; Tavichakorntrakool, R; Tippayawat, P; Wongthong, S | 1 |
| Akova, M; Aslan, AT; Dağ, O; Pashayev, T | 1 |
| Bojko, L; Borato, DCK; Borges, CL; Dionísio, LM; Moss, MF; Ripka, GP | 1 |
| Bostrom, MP; Carli, AV; Driscoll, DA; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X | 1 |
| Duong, L; Harriott, NG; Ives, AL; Pan-Chen, S; Rungkitwattanakul, D | 1 |
| Feng, YD; Jin, L; Wang, LH; Xu, GH; Zhang, XW; Zhou, FL | 1 |
| Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS | 1 |
| Buchan, BW; Faron, ML; Ledeboer, NA; Scholtz, SL | 1 |
| Bailey, J; Barker, WT; Gallagher, L; Gasper, J; Hubble, VB; Manoil, C; Melander, C | 1 |
| Bahmany, S; Barzel, I; Hunfeld, NGM; Jessurun, JG; Koch, BCP; van der Kuy, PHM | 1 |
| Chung, KK; DeLuca, JP; Kress, AT; Reed, T; Selig, DJ; Stewart, IJ | 1 |
| Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
| Aguado, JM; Silva, JT | 1 |
| Bue, M; Hanberg, P; Kipp, JO; Knudsen, MB; Stilling, M; Tøstesen, SK; Vittrup, S | 1 |
| Chen, GB; Lu, HZ | 1 |
| Alt, V; Bärtl, S; Hitzenbichler, F; Lang, S; Rupp, M; Walter, N | 1 |
| Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
| Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
| Baczek, SM; Cohen, JA; Hodge, LA; Ingemi, AI; Kaplan, MC; Kiley, PS; Pearston, AP; Shaeffer, ZA; Soriano, KM; Stanley, JS; Talt, IE; Wilson, TJ; Yao, A | 1 |
| Liu, G; Qi, Y | 1 |
| Huang, B; Huang, D; Kuang, Y; Li, C; Li, H; Lin, J; Lin, Y; Wang, P; Zhou, W | 1 |
| Martinez, AI; Santos, CAQ; Trick, WE; Tseng, M; Varughese, CA; Won, SY; Zhang, H | 1 |
| Adeli-Sardou, M; Forootanfar, H; Ghafari-Shahrbabaki, SS; Jabari-Morouei, F; Mehrabani, M; Riahi-Madvar, S; Shakibaie, M | 1 |
| Liu, A; Sun, C; Xiang, Y; Yuan, Y; Zhao, L | 1 |
| Cai, Q; Cao, Y; Chen, C; Gao, P; Hou, FF; Hu, Y; Johnson, DW; Kong, Y; Li, G; Li, H; Liu, B; Liu, H; Liu, X; Lu, F; Nie, S; Shen, J; Shi, Y; Su, G; Tang, Y; Wan, Q; Weng, J; Xiao, C; Xie, D; Xu, G; Xu, H; Xu, X; Yang, Q; Zha, Y; Zhou, Y | 1 |
| Han, J; Nie, C; Pei, J; Ren, Z; Wang, C; Wang, J; Xu, F; Yang, H; Yang, J; Yang, S; Zhang, Q; Zheng, X | 1 |
| Chai, MG; Cotta, MO; Farkas, A; Roberts, JA | 1 |
| Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
| Barabino, P; Castagnola, E; Lorenzi, I; Pistorio, A | 1 |
| Hattori, N; Ishii, I; Nakada, TA; Niibe, Y; Suzuki, T; Yamazaki, S | 1 |
| Araújo, OR; Barbosa, LC; Carlesse, FAMC; Carreira, LY; Fonseca, FMCD; Lima, APC; Marques, LMA; Pignati, LT; Silva, AMPSD; Silva, DCBD; Sodré, JJM | 1 |
| Huang, J; Jin, Y; Pei, Y; Sun, Q | 1 |
| Armengol de la Hoz, MÁ; Becker, CD; Calvachi-Prieto, P; Celi, LA; Chen, AY; Chen, C; Dagan, A; Deng, CY; Johnson, AEW; Khazi-Syed, A; Scurlock, C | 1 |
| Bode-Böger, SM; Czorlich, P; Grensemann, J; Kluge, S; König, C; Martens-Lobenhoffer, J; Westphal, M | 1 |
| Bhassu, S; Kareem, SA; Kaur, CP; Kumar, S; Mohamad, S; Rajamanikam, A; Samudi, C; Venugopal, K; Yong, CC | 1 |
| Guo, Y; Huo, J; Mei, S; Shi, G; Zhang, B; Zhao, Z | 1 |
| Jono, H; Oda, K; Saito, H | 1 |
| Furuya, K; Ito, K; Makio, S; Shimada, T; Sugiyama, K | 1 |
| Hiddema, JS | 1 |
| Cotta, MO; Elhadi, M; Farkas, A; Imani, S; Kanji, S; Luque-Pardos, S; Roberts, JA; Sanches, C; Sandaradura, I; Scheetz, MH; Schellack, N; Tabah, A; Timsit, JF; Wilks, K; Williams, PG; Xie, J | 1 |
| Fukushima, S; Gotoh, K; Hagiya, H; Otsuka, F; Uda, K | 1 |
| Alsaid, HM; Daoud, A; Sadaqa, D; Zeid, F | 1 |
| Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Gong, X; Hong, W; Li, J; Li, N; Shen, Y; Zhang, H | 1 |
| Junlin, Y; Lingzhu, LI; Luo Guangying, -; Meng Huaqing, -; Zha Zhuhong, - | 1 |
| Akcil, EF; Akyol, D; Altin, U; Amer, F; Arda, B; Aydemir, S; Bardak-Ozcem, S; Cesur, S; Cicek-Senturk, G; Erdem, HA; Ergen, P; Gautam, V; Kandemir, O; Kaya, S; Kurtaran, B; Mermer, S; Onal, U; Ormen, B; Ozdemir, K; Ozgiray, E; Oztoprak, N; Popescu, CP; Pullukcu, H; Saed, MA; Sakci, M; Sharma, M; Sipahi, H; Sipahi, OR; Suntur, BM; Tasbakan, M; Tukenmez-Tigen, E; Turunc, T; Ulusoy, S; Yamazhan, T; Yurtseven, T | 1 |
8 review(s) available for vancomycin and meropenem
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fulminant Listeria monocytogenes meningitis complicated with acute hydrocephalus in healthy children beyond the newborn period.
Topics: Acute Disease; Amikacin; Cefotaxime; Child; Child, Preschool; Combined Modality Therapy; Costa Rica; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Emergencies; Fatal Outcome; Female; Humans; Hydrocephalus; Male; Meningitis, Listeria; Meropenem; Rifampin; Thienamycins; Tomography, X-Ray Computed; Vancomycin; Ventriculostomy | 2004 |
Peritoneal-dialysis related peritonitis caused by Gordonia species: report of four cases and literature review.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Device Removal; Disease Management; Gordonia Bacterium; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prosthesis-Related Infections; Recurrence; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature.
Topics: Anti-Bacterial Agents; Cholesterol; Cholesterol, HDL; Drug Therapy, Combination; Fasting; Female; Humans; Hypertriglyceridemia; Infant; Lipid Metabolism; Lipids; Meropenem; Osteomyelitis; Thienamycins; Triglycerides; Vancomycin | 2016 |
[Pharmacotherapy and kidney dysfunction].
Topics: Anti-Bacterial Agents; Critical Illness; Glomerular Filtration Rate; Humans; Kidney Diseases; Meropenem; Pharmacokinetics; Piperacillin; Vancomycin | 2019 |
Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Baclofen; Brain Diseases; Electroencephalography; Fever; GABA-B Receptor Agonists; Humans; Infusion Pumps, Implantable; Infusions, Spinal; Male; Meropenem; Paraplegia; Seizures; Spasm; Spinal Cord Injuries; Vancomycin | 2020 |
[Pharmacokinetics and pharmacodynamics in extracorporeal renal replacement therapy].
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Meropenem; Piperacillin; Renal Dialysis; Renal Replacement Therapy; Vancomycin | 2021 |
Brain abscess due to Aggregatibacter aphrophilus in association with atrial septal defect：Case report and literature review.
Topics: Adult; Aggregatibacter aphrophilus; Anti-Bacterial Agents; Brain Abscess; Child; Endocarditis; Female; Heart Defects, Congenital; Heart Septal Defects, Atrial; Humans; Hypertension, Pulmonary; Meropenem; Middle Aged; Pasteurellaceae Infections; Vancomycin | 2022 |
5 trial(s) available for vancomycin and meropenem
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Prospective Studies; Renal Dialysis; Risk Assessment; Thienamycins; Treatment Outcome; Vancomycin | 2006 |
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Load; Blood Glucose; Diarrhea; Fasting; Feces; Gastrointestinal Hormones; Gastrointestinal Microbiome; Gentamicins; Glucose; Humans; Insulin; Male; Meropenem; Postprandial Period; Thienamycins; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Does the use of a closed-suction drain reduce the effectiveness of an antibiotic-loaded spacer in two-stage exchange Arthroplasty for Periprosthetic hip infection? A prospective, randomized, controlled study.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Bone Cements; Female; Hip Joint; Hip Prosthesis; Humans; Male; Meropenem; Methylmethacrylate; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Suction; Treatment Outcome; Vancomycin | 2019 |
Drug dosing using estimated glomerular filtration rate: Misclassification due to metamizole interference in a creatinine assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Creatinine; Cross-Sectional Studies; Dipyrone; Female; Glomerular Filtration Rate; Humans; Male; Meropenem; Middle Aged; Vancomycin | 2021 |
221 other study(ies) available for vancomycin and meropenem
| Article | Year |
|---|---|
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
Topics: Bacterial Proteins; Cell Lineage; DNA Transposable Elements; Genetic Variation; Poland; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Hairless; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Thiol activated prodrugs of sulfur dioxide (SO2) as MRSA inhibitors.
Topics: Anti-Bacterial Agents; Drug Design; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcal Infections; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfur Dioxide | 2015 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Synthesis and bioactivities study of new antibacterial peptide mimics: The dialkyl cationic amphiphiles.
Topics: Alkylation; Anti-Bacterial Agents; Bacteria; Biofilms; Cell Membrane Permeability; Chemistry Techniques, Synthetic; Drug Resistance, Multiple; Drug Stability; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Peptidomimetics | 2018 |
Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
Topics: Anti-Bacterial Agents; Cations; Chalcone; Dose-Response Relationship, Drug; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Salmonella enterica; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Topics: Anti-Bacterial Agents; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface-Active Agents | 2018 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Design, synthesis and activity against drug-resistant bacteria evaluation of C-20, C-23 modified 5-O-mycaminosyltylonolide derivatives.
Topics: Animals; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Leucomycins; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Topics: Carbapenems; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Gentamicins; Kinetics; Meropenem; Methicillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 1989 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1997 |
[In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Topics: Anti-Bacterial Agents; Carbapenems; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
Topics: Animals; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1999 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Successful medical treatment of acute bilateral emphysematous pyelonephritis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Combined Modality Therapy; Diabetes Mellitus, Type 2; Emphysema; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Pyelonephritis; Sepsis; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
Topics: Anti-Bacterial Agents; Aztreonam; Borrelia burgdorferi Group; Drug Resistance, Microbial; Fusidic Acid; Humans; Meropenem; Mezlocillin; Microbial Sensitivity Tests; Monobactams; Penicillins; Ribostamycin; Teicoplanin; Thienamycins; Vancomycin | 2001 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain.
Topics: Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Severity of Illness Index; Spinal Puncture; Streptococcus pneumoniae; Thienamycins; Treatment Failure; Vancomycin | 2001 |
Bullous pemphigoid complicated by nonfatal necrotizing fasciitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Fasciitis, Necrotizing; Female; Humans; Leg; Meropenem; Pemphigoid, Bullous; Thienamycins; Treatment Outcome; Ultrasonography; Vancomycin | 2003 |
[Antimicrobial susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae isolated from children with meningitis].
Topics: Ampicillin; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Infant; Meningitis; Meropenem; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2004 |
Withholding initial vancomycin in febrile neutropenia despite implanted catheters.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Child; Child, Preschool; Drug Resistance, Bacterial; Fever; Humans; Infant; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Thienamycins; Vancomycin | 2004 |
Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Colitis; Female; Interleukin-4; Lactobacillus; Limosilactobacillus reuteri; Meropenem; Mice; Mice, Inbred BALB C; Mice, SCID; Probiotics; Rectum; Thienamycins; Vancomycin; Water Supply | 2005 |
Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis.
Topics: Acute Kidney Injury; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Renal Dialysis; Risk Assessment; Thienamycins; Treatment Outcome; Vancomycin | 2006 |
Bilateral psoas abscesses post-peripheral blood stem cell transplantation.
Topics: Adult; Cyclosporine; Drainage; Female; Humans; Meropenem; Peripheral Blood Stem Cell Transplantation; Psoas Abscess; Recurrence; Remission Induction; Sensitivity and Specificity; Thienamycins; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Mechanical effects of the use of vancomycin and meropenem in acrylic bone cement.
Topics: Anti-Bacterial Agents; Biomechanical Phenomena; Bone Cements; Drug Combinations; Joint Prosthesis; Materials Testing; Meropenem; Particle Size; Polymethyl Methacrylate; Stress, Mechanical; Tensile Strength; Thienamycins; Vancomycin | 2006 |
Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin | 2006 |
Chryseobacterium meningosepticum infection and cardiac tamponade in a long-term hemodialysis patient.
Topics: Aged; Anti-Bacterial Agents; Cardiac Tamponade; Chryseobacterium; Ciprofloxacin; Fatal Outcome; Flavobacteriaceae Infections; Humans; Kidney Failure, Chronic; Male; Meropenem; Pericarditis; Renal Dialysis; Thienamycins; Vancomycin | 2006 |
Brain abscess caused by Streptococcus pyogenes in a previously healthy child.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Brain Abscess; California; Dexamethasone; Drainage; Humans; Infant; Male; Meropenem; Streptococcal Infections; Streptococcus pyogenes; Thienamycins; Vancomycin | 2006 |
[Catheter associated Staphylococcus sciuri sepsis in a patient with acute myeloid leukemia].
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Drug Resistance, Bacterial; Female; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Neutropenia; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Thienamycins; Vancomycin | 2006 |
Rhodococcus lung abscess complicating kidney transplantation: successful management by combination antibiotic therapy.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Transplantation; Lung Abscess; Male; Meropenem; Radiography; Rhodococcus equi; Rifampin; Sirolimus; Thienamycins; Treatment Outcome; Vancomycin | 2008 |
Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy.
Topics: Anemia; Anti-Bacterial Agents; Cardiomyopathies; Cardiotonic Agents; Dopamine; Electrocardiography; Hemolytic-Uremic Syndrome; Humans; Infant; Intubation, Intratracheal; Male; Meropenem; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Oliguria; Peritoneal Dialysis; Renal Dialysis; Renal Insufficiency; Respiration, Artificial; Thienamycins; Vancomycin | 2007 |
Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Ceftazidime; Cerebrospinal Fluid Shunts; Child; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Megakaryoblastic, Acute; Male; Meningitis, Bacterial; Meropenem; Micrococcaceae; Opportunistic Infections; Postoperative Complications; Rifampin; Sepsis; Thienamycins; Vancomycin | 2008 |
Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action.
Topics: Anti-Bacterial Agents; Bone Cements; Meropenem; Polymethyl Methacrylate; Thienamycins; Vancomycin | 2008 |
Infective endoshuntitis in a patient with non-cirrhotic portal hypertension: successful medical management.
Topics: Adult; Anti-Bacterial Agents; Humans; Hypertension, Portal; Male; Meropenem; Portasystemic Shunt, Transjugular Intrahepatic; Prosthesis-Related Infections; Thienamycins; Vancomycin | 2009 |
Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement.
Topics: Anti-Bacterial Agents; Biomechanical Phenomena; Chemistry, Pharmaceutical; Drug Delivery Systems; Enterococcus; Escherichia coli; Humans; Meropenem; Polymethyl Methacrylate; Prosthesis-Related Infections; Pseudomonas; Staphylococcus; Thienamycins; Vancomycin | 2008 |
Fever, hip pain, and headache in a 12-year-old girl.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Headache; Hip; Humans; Magnetic Resonance Imaging; Meropenem; Thienamycins; Tomography, X-Ray Computed; Vancomycin | 2008 |
Foreign-body reaction mimicking postneurosurgical infection after cranioplasty.
Topics: Anti-Bacterial Agents; Brain Diseases; Craniotomy; Female; Foreign Bodies; Foreign-Body Reaction; Humans; Infections; Meropenem; Middle Aged; Postoperative Complications; Thienamycins; Time Factors; Vancomycin | 2008 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
"Moraxella lacunata" endocarditis treated with penicillin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Gentamicins; Humans; Male; Meropenem; Metronidazole; Moraxellaceae Infections; Penicillins; Protein Synthesis Inhibitors; Thienamycins; Vancomycin | 2008 |
Prevention and treatment of penicillin-resistant Streptococcus pneumoniae meningitis after intracraniofacial surgery with distraction osteogenesis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Craniofacial Dysostosis; Drug Combinations; Female; Follow-Up Studies; Frontal Bone; Humans; Meningitis, Pneumococcal; Meropenem; Osteogenesis, Distraction; Osteotomy; Osteotomy, Le Fort; Penicillin Resistance; Streptococcus pneumoniae; Surgical Wound Infection; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2008 |
[Two cases of vancomycin-intermediate Staphylococcus aureus isolated from joint tissue or wound].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Humans; Joints; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pressure Ulcer; Staphylococcal Infections; Thienamycins; Vancomycin; Vancomycin Resistance | 2008 |
Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Meningitis, Pneumococcal; Meropenem; Microbial Viability; Rifampin; Streptococcus pneumoniae; Thienamycins; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Calciphylaxis in a cardiac patient without renal disease.
Topics: Alcoholism; Anti-Bacterial Agents; Anticoagulants; Calciphylaxis; Clindamycin; Diphosphonates; Female; Heart Diseases; Humans; Kidney Failure, Chronic; Meropenem; Middle Aged; Risk Factors; Thienamycins; Vancomycin; Warfarin | 2009 |
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Listeria monocytogenes meningitis in two immunocompetent children.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Immunocompetence; Infant; Listeriosis; Male; Meningitis, Listeria; Meropenem; Risk Factors; Spinal Puncture; Thienamycins; Vancomycin | 2009 |
"Typhlitis" in rectum.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Meropenem; Netilmicin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proctitis; Thienamycins; Tomography, X-Ray Computed; Typhlitis; Vancomycin | 2010 |
Neonatal community-acquired pneumonia: pathogens and treatment.
Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin | 2010 |
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Incidence; Meropenem; Microbial Sensitivity Tests; Phylogeny; Thienamycins; Vancomycin; Vancomycin Resistance | 2010 |
[Antibiotic susceptibility of blood-borne Streptococcus pneumoniae and efficacy assessment of respiratory quinolones using Monte Carlo simulation].
Topics: Anti-Bacterial Agents; Blood; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Humans; Imipenem; Meropenem; Monte Carlo Method; Mutation; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2010 |
[Successful conservative therapy of an infected, percutaneously implanted, infrarenal aortic stent].
Topics: Administration, Oral; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Atherosclerosis; Blood Vessel Prosthesis Implantation; Clindamycin; Drug Therapy, Combination; Endoleak; Humans; Infusions, Intravenous; Male; Meropenem; Middle Aged; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Stents; Thienamycins; Tomography, X-Ray Computed; Vancomycin | 2011 |
Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bronchoscopy; Child; Fatal Outcome; Female; Fibrinolytic Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Meropenem; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Respiratory Distress Syndrome; Respiratory Insufficiency; Staphylococcal Infections; Thienamycins; Tissue Plasminogen Activator; Vancomycin | 2011 |
Fulminant ependymitis following intraventricular rupture of brain abscess.
Topics: Anti-Bacterial Agents; Brain Abscess; Cerebrospinal Fluid Shunts; Ependyma; Humans; Hydrocephalus; Male; Meningitis, Bacterial; Meropenem; Middle Aged; Rupture, Spontaneous; Thienamycins; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Abscess of the medulla oblongata in a toddler: case report and technical considerations based on magnetic resonance imaging tractography.
Topics: Ampicillin; Anti-Bacterial Agents; Brain Abscess; Diffusion Tensor Imaging; Female; Humans; Infant; Medulla Oblongata; Meropenem; Neurosurgical Procedures; Staphylococcal Infections; Staphylococcus hominis; Thienamycins; Vancomycin | 2011 |
Adult de novo lumbar scoliosis. Posterior instrumented fusion with Smith-Peterson osteotomy, decompression and management of postoperative infection.
Topics: Anti-Bacterial Agents; Decompression, Surgical; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Lumbar Vertebrae; Meropenem; Middle Aged; Osteotomy; Pseudomonas aeruginosa; Pseudomonas Infections; Scoliosis; Spinal Fusion; Surgical Wound Infection; Thienamycins; Treatment Outcome; Vancomycin | 2011 |
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Topics: Adult; Age Factors; Aged; Bacteremia; Bone Marrow Transplantation; Case-Control Studies; Catheterization, Central Venous; Enterococcus; Female; Gastrointestinal Diseases; Hospitals; Humans; Hypoalbuminemia; Male; Meropenem; Metronidazole; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Phenotype; Risk Factors; Thienamycins; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2012 |
[Use of the critical path with the electronic chart system using meropenem, vancomycin, liposome amphotericin B for the febrile neutropenia].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Critical Pathways; Drug Therapy, Combination; Electronic Health Records; Female; Fever; Hematologic Neoplasms; Humans; Liposomes; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins; Treatment Outcome; Vancomycin; Young Adult | 2011 |
[A case of neonatal meningitis due to Listeria monocytogenes serotype 1/2b].
Topics: Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeria monocytogenes; Meningitis, Listeria; Meropenem; Microbial Sensitivity Tests; Serotyping; Thienamycins; Vancomycin | 2011 |
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aortic Valve; Aza Compounds; Biopsy; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Endocarditis, Bacterial; Eosinophilia; Fluoroquinolones; Glucocorticoids; Humans; Kidney; Legionnaires' Disease; Male; Meropenem; Moxifloxacin; Nephritis, Interstitial; Quinolines; Sepsis; Skin; Thienamycins; Vancomycin | 2012 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
[Case of meningitis caused by group B Streptococcus treated with high dose of meropenem].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Linezolid; Male; Meningitis, Bacterial; Meropenem; Oxazolidinones; Pulse Therapy, Drug; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Thienamycins; Treatment Outcome; Vancomycin | 2011 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin | 2012 |
Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Enzyme Inhibitors; Esomeprazole; Meropenem; Microbial Sensitivity Tests; Proton Pump Inhibitors; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 2012 |
Endogenous endophthalmitis caused by salmonella serotype B in an immunocompetent 12-year-old child.
Topics: Anti-Bacterial Agents; Ceftazidime; Child; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Feces; Humans; Immunocompetence; Male; Meropenem; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Vancomycin; Visual Acuity; Vitreous Body | 2012 |
Pyomyositis of the piriformis muscle presenting with sciatica in a teenage rugby player.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Floxacillin; Football; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Meropenem; Pain; Piriformis Muscle Syndrome; Pyomyositis; Rifampin; Sciatica; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 2012 |
Pott's puffy tumour and intracranial complications of frontal sinusitis in pregnancy.
Topics: Anti-Bacterial Agents; Catheterization; Ceftriaxone; Cesarean Section; Drainage; Drug Therapy, Combination; Endoscopy; Female; Frontal Sinusitis; Headache; Humans; Magnetic Resonance Imaging; Meropenem; Orbital Cellulitis; Patient Care Team; Pott Puffy Tumor; Pregnancy; Pregnancy Complications, Infectious; Streptococcal Infections; Thienamycins; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations.
Topics: Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Drug Monitoring; Drug Therapy, Combination; Humans; Hydrocephalus; Male; Meropenem; Subarachnoid Hemorrhage; Thienamycins; Vancomycin; Ventriculostomy | 2013 |
Bacillus cereus fasciitis: a unique pathogen and clinically challenging sequela of inoculation.
Topics: Anti-Bacterial Agents; Bacillus cereus; Child; Clindamycin; Debridement; Fasciitis; Fasciotomy; Gram-Positive Bacterial Infections; Humans; Lower Extremity; Male; Meropenem; Reoperation; Soft Tissue Infections; Therapeutic Irrigation; Thienamycins; Vancomycin; Wounds, Penetrating | 2013 |
Salmonella enterica serovar Minnesota urosepsis in a patient with Crohn's disease in the absence of recent or current gastrointestinal symptoms.
Topics: Adult; Antibodies, Monoclonal; Ceftriaxone; Crohn Disease; Humans; Infliximab; Male; Meropenem; Recurrence; Salmonella enterica; Salmonella Infections; Sepsis; Thienamycins; Urinary Catheters; Urinary Tract Infections; Urolithiasis; Vancomycin | 2013 |
Capnocytophaga canimorsus sepsis following BMT in a patient with AML: possible association with functional asplenia.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Disease Progression; Dog Diseases; Dogs; Female; Graft vs Host Disease; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Postoperative Complications; Saliva; Sepsis; Spleen; Thienamycins; Thrombocytosis; Treatment Outcome; Vancomycin | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Multiple organ damage caused by a novel tick-borne Bunyavirus: a case report.
Topics: Animals; Anti-Bacterial Agents; Bunyaviridae Infections; Female; Humans; Meropenem; Middle Aged; Multiple Organ Failure; Orthobunyavirus; Thienamycins; Tick-Borne Diseases; Ticks; Treatment Outcome; Vancomycin | 2013 |
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Piperacillin; Renal Replacement Therapy; Thienamycins; Vancomycin | 2014 |
Parietal subdural empyema as complication of acute odontogenic sinusitis: a case report.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Craniotomy; Diagnosis, Differential; Empyema, Subdural; Follow-Up Studies; Humans; Male; Maxillary Sinus; Meropenem; Metronidazole; Parietal Lobe; Sinusitis; Subdural Space; Thienamycins; Tomography, X-Ray Computed; Tooth Extraction; Treatment Outcome; Vancomycin | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Interactions; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Thienamycins; Vancomycin | 2015 |
Secondary Bacteremia: A Serious Complication of Rotavirus Gastroenteritis in Neonates.
Topics: Anti-Bacterial Agents; Bacteremia; Female; Gastroenteritis; Humans; Infant, Newborn; Male; Meropenem; Rotavirus Infections; Thienamycins; Vancomycin | 2015 |
Multiple necrotic deep wound infections associated with a subcutaneous immunoglobulin infusion.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Cellulitis; Clindamycin; Combined Modality Therapy; Common Variable Immunodeficiency; Debridement; Drug Substitution; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infusions, Subcutaneous; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Pyoderma Gangrenosum; Reoperation; Staphylococcal Infections; Thienamycins; Vancomycin; Wound Infection | 2015 |
Severe Sepsis due to Otogenic Pneumococcal Meningitis with Pneumocephalus without Meningeal Symptoms.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Dexamethasone; Humans; Male; Meningitis, Bacterial; Meningitis, Pneumococcal; Meropenem; Pneumocephalus; Thienamycins; Treatment Outcome; Vancomycin | 2015 |
Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin | 2016 |
The characteristics of post-neurosurgical bacterial meningitis in elective neurosurgery in 2012: A single institute study.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; China; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis, Bacterial; Meropenem; Middle Aged; Neurosurgical Procedures; Polymyxins; Postoperative Complications; Pseudomonas Infections; Retrospective Studies; Seasons; Staphylococcal Infections; Sulfamethoxazole; Thienamycins; Vancomycin; Young Adult | 2015 |
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin; Young Adult | 2015 |
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Fecal Incontinence; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Metronidazole; Middle Aged; Organ Transplantation; Respiration, Artificial; Risk Factors; Stem Cell Transplantation; Thienamycins; Time Factors; Vancomycin | 2016 |
[Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia].
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Chromatography, High Pressure Liquid; Clindamycin; Female; Humans; Ischemia; Levofloxacin; Linezolid; Lower Extremity; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Skin; Thienamycins; Vancomycin | 2016 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
[Combined intravenous and intrathecal vancomycin in treatment of patients with intracranial infections after craniotomy].
Topics: Central Nervous System Infections; Cephalosporins; Craniotomy; Humans; Injections, Intravenous; Injections, Spinal; Meropenem; Retrospective Studies; Thienamycins; Vancomycin | 2016 |
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin | 2017 |
Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Tetracyclines; Thienamycins; Tigecycline; Vancomycin | 2016 |
Appendicitis in an Infant with Atypical Features.
Topics: Abscess; Acute Disease; Anti-Bacterial Agents; Appendectomy; Appendicitis; Humans; Immunoglobulins; Infant; Meropenem; Rupture, Spontaneous; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2016 |
Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Culture Media; Drug Stability; Limit of Detection; Linezolid; Meropenem; Thienamycins; Vancomycin | 2016 |
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Aztreonam; Bacteremia; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Rifampin; Teicoplanin; Thienamycins; Vancomycin | 2016 |
Purple Urine Bag Syndrome.
Topics: Aged; Anti-Bacterial Agents; Catheters, Indwelling; Female; Humans; Hydrogen-Ion Concentration; Indoles; Meropenem; Thienamycins; Urinary Catheterization; Urinary Catheters; Urinary Tract Infections; Urine; Vancomycin | 2016 |
Sonographic appearance of pyomyositis of the sternocleidomastoid muscle: A case report.
Topics: Anti-Bacterial Agents; Drainage; Humans; Male; Meropenem; Middle Aged; Neck Muscles; Pyomyositis; Thienamycins; Treatment Outcome; Ultrasonography; Vancomycin | 2017 |
Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information.
Topics: Anti-Bacterial Agents; Computer Simulation; Drug Therapy, Combination; In Vitro Techniques; Linezolid; Meropenem; Microbial Sensitivity Tests; Models, Theoretical; Staphylococcus aureus; Thienamycins; Translational Research, Biomedical; Vancomycin | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Mycoses; Penicillins; Retrospective Studies; Thienamycins; Vancomycin | 2018 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
Case Report: Fatal Pediatric Melioidosis Despite Optimal Intensive Care.
Topics: Anti-Bacterial Agents; Australia; Burkholderia pseudomallei; Child; Fatal Outcome; Humans; Intensive Care Units; Lincomycin; Male; Melioidosis; Meropenem; Papua New Guinea; Sulfamethoxazole; Thienamycins; Trimethoprim; Vancomycin | 2017 |
Seven-Year-Old Girl With Forehead Swelling.
Topics: Anti-Bacterial Agents; Child; Craniotomy; Drainage; Endoscopy; Epidural Abscess; Female; Fusobacterium Infections; Humans; Magnetic Resonance Imaging; Meropenem; Paranasal Sinuses; Pott Puffy Tumor; Staphylococcal Infections; Thienamycins; Tomography, X-Ray Computed; Vancomycin | 2017 |
Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
A successful treatment of necrotizing fasciitis following the surgery of distal radius plate removal: A case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Bone Plates; Cefonicid; Debridement; Decompression, Surgical; Device Removal; Disease Progression; Fasciitis, Necrotizing; Forearm; Fracture Fixation; Humans; Magnetic Resonance Imaging; Male; Meropenem; Radius Fractures; Reoperation; Streptococcus pyogenes; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2018 |
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Logistic Models; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Thienamycins; Vancomycin | 2018 |
Effect of Intraoperative Single-Shot Application of Vancomycin in Liver Transplant Recipients on Postoperative Infections With Enterococcus faecium and Enterococcus faecalis.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Enterococcus faecalis; Enterococcus faecium; Female; Germany; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intraoperative Care; Liver Transplantation; Male; Meropenem; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cell Membrane Permeability; Drug Synergism; Enzyme Activation; Female; Gene Expression Regulation, Bacterial; Gram-Negative Bacteria; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Mice; Molecular Structure; Vancomycin | 2018 |
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Levofloxacin; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae; Tigecycline; Vancomycin | 2018 |
Maternal ventriculoperitoneal shunt infection due to Corynebacterium xerosis following caesarean section.
Topics: Anti-Bacterial Agents; Cesarean Section; Corynebacterium; Corynebacterium Infections; Female; Humans; Hydrocephalus; Meropenem; Pregnancy; Vancomycin; Ventriculoperitoneal Shunt; Young Adult | 2019 |
Occult community acquired Klebsiella pneumoniae purulent meningitis in an adult: A case report.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Fatal Outcome; Fever; Headache; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Meropenem; Middle Aged; Shock, Septic; Thienamycins; Vancomycin | 2018 |
A case report of hemolytic streptococcal gangrene in the danger triangle of the face with thrombocytopenia and hepatitis.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Early Diagnosis; Face; Gangrene; Hepatitis; Humans; Infant; Male; Meropenem; Penicillin G; Streptococcal Infections; Streptococcus pyogenes; Thrombocytopenia; Vancomycin | 2018 |
A decision support system for antibiotic prescription based on local cumulative antibiograms.
Topics: Algorithms; Anti-Bacterial Agents; Antimicrobial Stewardship; Decision Support Systems, Clinical; Electronic Health Records; Hospitals; Humans; Imipenem; Linezolid; Meropenem; Microbial Sensitivity Tests; Prescriptions; Reproducibility of Results; Software; Vancomycin | 2018 |
In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacter cloacae; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Vancomycin | 2018 |
Beta-lactam carryover in arterial and central venous catheters is negligible.
Topics: Animals; Catheters, Indwelling; Cattle; Cefepime; Central Venous Catheters; Chromatography, High Pressure Liquid; Meropenem; Piperacillin; Vancomycin | 2018 |
Patch testing with meropenem following a severe cutaneous adverse drug reaction.
Topics: Anti-Bacterial Agents; Female; Humans; Hypersensitivity, Delayed; Meningeal Neoplasms; Meropenem; Middle Aged; Patch Tests; Vancomycin | 2018 |
Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Female; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Pseudomonas Infections; Severity of Illness Index; Vancomycin | 2019 |
Clinical Application of Pharmacokinetics: Basis for Rational Dose Selection in a Critically Ill Patient on Renal Replacement Therapy.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Meropenem; Metabolic Clearance Rate; Renal Dialysis; Sepsis; Time Factors; Treatment Outcome; Vancomycin | 2019 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
Reduction of Inappropriate Antimicrobial Prescriptions in a Tertiary Neonatal Intensive Care Unit After Antimicrobial Stewardship Care Bundle Implementation.
Topics: Anti-Infective Agents; Antimicrobial Stewardship; Drug Utilization; Humans; Inappropriate Prescribing; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Meropenem; Patient Care Bundles; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2019 |
Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Communicable Diseases; Cost-Benefit Analysis; Drug Utilization; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Saudi Arabia; Tertiary Care Centers; Vancomycin; Young Adult | 2018 |
Infectious complications after surgery for a frontal meningioma.
Topics: Aged; Anti-Bacterial Agents; Craniotomy; Drug Resistance, Multiple, Bacterial; Empyema; Enterobacteriaceae Infections; Humans; Male; Meningeal Neoplasms; Meropenem; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Seizures; Spinal Puncture; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2019 |
Antimicrobial stewardship program (ASP): an effective implementing technique for the therapy efficiency of meropenem and vancomycin antibiotics in Iranian pediatric patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antimicrobial Stewardship; Blood Culture; Chi-Square Distribution; Drug Administration Schedule; Hospitals, Pediatric; Humans; Infant; Iran; Length of Stay; Meropenem; Mortality; Prescription Drugs; Program Evaluation; Time Factors; Treatment Outcome; Vancomycin | 2019 |
Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem.
Topics: Acute Kidney Injury; Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Meropenem; Retrospective Studies; Vancomycin | 2019 |
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin | 2019 |
Antibiotic Prophylaxis for Open Chest Management After Pediatric Cardiac Surgery.
Topics: Age Factors; Antibiotic Prophylaxis; Bacteremia; Cardiac Surgical Procedures; Cefazolin; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Meropenem; Postoperative Complications; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2019 |
Neonatal Acquired Methemoglobinemia - Can Broad Spectrum Antibiotics be Implicated?
Topics: Anti-Bacterial Agents; Cyanosis; Female; Humans; Infant, Newborn; Male; Meropenem; Methemoglobinemia; Tigecycline; Vancomycin | 2019 |
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult | 2019 |
Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
Topics: Adult; Aged; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies; Vancomycin | 2019 |
Does an Antimicrobial Time-Out Impact the Duration of Therapy of Antimicrobials in the PICU?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug Utilization; Duration of Therapy; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Piperacillin, Tazobactam Drug Combination; Quality of Health Care; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2019 |
Encephalitis caused by Listeria monocytogenes in a healthy adult male in China: A case report.
Topics: Adult; Anti-Bacterial Agents; China; Diuretics, Osmotic; Emergency Service, Hospital; Encephalitis; Humans; Listeria monocytogenes; Listeriosis; Male; Mannitol; Meropenem; Tomography, X-Ray Computed; Vancomycin | 2019 |
[A case of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) associated with infectious endocarditis caused by Staphylococcus aureus].
Topics: Adolescent; Anti-Bacterial Agents; Corpus Callosum; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Female; Humans; Infectious Encephalitis; Meropenem; Mitral Valve Annuloplasty; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2019 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
[Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Doripenem; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk; Vancomycin | 2019 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE.
Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Heart Diseases; Hospitalization; Hospitals, Teaching; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Pharmacists; Pharmacy Service, Hospital; Prospective Studies; Safety; Treatment Outcome; Vancomycin | 2020 |
Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Comorbidity; Creatinine; Diuretics; Female; Heart Failure; Hong Kong; Humans; Incidence; Infant; Infant, Newborn; Length of Stay; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency, Chronic; Respiratory Insufficiency; Risk Factors; Vancomycin; Young Adult | 2020 |
Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency Dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Hybrid Renal Replacement Therapy; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Young Adult | 2020 |
Necrotising fasciitis.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Clindamycin; Coinfection; Debridement; Diabetes Mellitus, Type 2; Fasciitis, Necrotizing; Female; Fluid Therapy; Humans; Meropenem; Methicillin-Resistant Staphylococcus aureus; Obesity; Renal Insufficiency, Chronic; Resuscitation; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2020 |
Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Critical Care; Duration of Therapy; Female; Humans; Intensive Care Units; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Clostridium Infections; Comorbidity; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Iran; Male; Meropenem; Middle Aged; Neoplasms; Prevalence; Program Evaluation; Vancomycin; Young Adult | 2020 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Cross-Sectional Studies; Drug Monitoring; Germany; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Physicians; Piperacillin; Surveys and Questionnaires; Treatment Outcome; Vancomycin | 2020 |
Clostridium tertium Peritonitis and Bacteremia in a Neonate With Congenital Intestinal Atresia: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridium Infections; Clostridium tertium; Female; Humans; Infant, Newborn; Meropenem; Peritonitis; Splenic Infarction; Vancomycin | 2021 |
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Clostridioides; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Skull base osteomyelitis with secondary cavernous sinus thrombosis: a rare presentation of an animate foreign body in the ear.
Topics: Adult; Amphotericin B; Animals; Cavernous Sinus; Cavernous Sinus Thrombosis; Coleoptera; Drainage; Drug Therapy, Combination; Enoxaparin; Eye Foreign Bodies; Fatal Outcome; Female; Humans; Hyphae; Magnetic Resonance Imaging; Meropenem; Mucorales; Mucormycosis; Osteomyelitis; Skull Base; Vancomycin | 2021 |
Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2021 |
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Topics: Adult; Algorithms; Clostridioides difficile; Febrile Neutropenia; Humans; Interrupted Time Series Analysis; Meropenem; Vancomycin | 2021 |
Successful treatment of a patient with multi-site infection of cerebrospinal fluid and testis due to Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefoperazone; Cerebrospinal Fluid; Drug Combinations; Epididymis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Magnetic Resonance Imaging; Male; Meropenem; Middle Aged; Perineum; Skull; Sulbactam; Testis; Ultrasonography; Vancomycin | 2021 |
Antibiotics Removal by Continuous Venovenous Hemofiltration with a Novel Asymmetric Triacetate Membrane Hemofilter: An in vitro Study.
Topics: Acetates; Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Daptomycin; Filtration; Hemofiltration; Humans; Membranes, Artificial; Meropenem; Vancomycin | 2021 |
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2021 |
Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Tertiary Care Centers; Vancomycin | 2021 |
Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.
Topics: Amikacin; Anti-Bacterial Agents; Calcium Sulfate; Cefazolin; Meropenem; Minocycline; Tobramycin; Vancomycin | 2022 |
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Elution and Biomechanical Properties of Meropenem-Loaded Bone Cement.
Topics: Anti-Bacterial Agents; Biomechanical Phenomena; Bone Cements; Compressive Strength; Humans; Materials Testing; Meropenem; Polymethyl Methacrylate; Powders; Vancomycin | 2021 |
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin | 2022 |
Comparison of Methods for Determining the Antibiotic Susceptibility of Aerococcus Species in a Clinical Setting.
Topics: Aerococcus; Agar; Animals; Anti-Bacterial Agents; Humans; Linezolid; Meropenem; Microbial Sensitivity Tests; Sheep; Tetracyclines; Vancomycin | 2022 |
Genetic Dissection of Antibiotic Adjuvant Activity.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Clarithromycin; Meropenem; Microbial Sensitivity Tests; Vancomycin | 2022 |
Evaluation of the importance of mixing during preparation of antibiotic infusions.
Topics: Anti-Bacterial Agents; Cefuroxime; Floxacillin; Infusions, Intravenous; Meropenem; Vancomycin | 2022 |
Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
Topics: Anti-Bacterial Agents; Critical Illness; Gentamicins; Hemoperfusion; Humans; Imipenem; Meropenem; Vancomycin | 2023 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |
Current state of antimicrobial stewardship and organ transplantation in Spain.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Ciprofloxacin; Humans; Meropenem; Organ Transplantation; Spain; Vancomycin | 2022 |
Concentrations of co-administered vancomycin and meropenem in the internal dead space of a cannulated screw and in cancellous bone adjacent to the screw - Evaluated by microdialysis in a porcine model.
Topics: Animals; Anti-Bacterial Agents; Cancellous Bone; Female; Meropenem; Microdialysis; Swine; Vancomycin | 2022 |
[Antibiotic use for prophylaxis and empirical therapy of fracture-related infections in Germany : A survey of 44 hospitals].
Topics: Anti-Bacterial Agents; Cephalosporins; Fracture Fixation, Internal; Fractures, Open; Hospitals; Humans; Meropenem; Penicillins; Surveys and Questionnaires; Vancomycin | 2023 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Critical Illness; Drug Monitoring; Humans; Imipenem; Linezolid; Meropenem; Micafungin; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Tigecycline; Vancomycin; Voriconazole | 2022 |
Antibiotic-induced depletion of
Topics: Animals; Anti-Bacterial Agents; Clostridium; Fatty Acids, Volatile; Humans; Immunoglobulin A; Infant, Newborn; Infant, Premature; Interleukin-10; Invasive Fungal Infections; Meropenem; Mycoses; Rats; RNA, Ribosomal, 16S; Vancomycin | 2022 |
Computing antimicrobial use/antimicrobial resistance ratios: A novel way to assess inpatient antimicrobial utilization using current National Healthcare Safety Network metrics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benchmarking; Carbapenems; COVID-19 Drug Treatment; Daptomycin; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Inpatients; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2022 |
Cytotoxicity and anti-biofilm activities of biogenic cadmium nanoparticles and cadmium nitrate: a preliminary study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cadmium; Gentamicins; Kanamycin; Meropenem; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Staphylococcus aureus; Streptomycin; Tetracyclines; Vancomycin | 2022 |
Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records.
Topics: Acyclovir; Aged; Agranulocytosis; Electronic Health Records; Ganciclovir; Humans; Meropenem; Neutropenia; Palonosetron; Thrombocytopenia; Vancomycin; Voriconazole | 2023 |
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Ceftazidime; Data Analysis; Drug Therapy, Combination; Female; Humans; Meropenem; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Sepsis; Vancomycin | 2023 |
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Humans; Meropenem; Piperacillin; Sepsis; Software; Vancomycin | 2023 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
Antibiotic defined daily dose in pediatrics. A single center study to proof the principle that a specific pediatric definition could be not needed.
Topics: Anti-Bacterial Agents; Body Weight; Child; Hospitalization; Humans; Meropenem; Vancomycin | 2023 |
Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report.
Topics: Hemodiafiltration; Humans; Meropenem; Renal Dialysis; Vancomycin | 2023 |
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
Topics: Anti-Bacterial Agents; Asparaginase; Busulfan; Cancer Care Facilities; Carboplatin; Case-Control Studies; Cefepime; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Melphalan; Meropenem; Neoplasms; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
A High-Performance Liquid Chromatography-Mass Spectrometry Method for Simultaneous Determination of Vancomycin, Meropenem, and Valproate in Patients with Post-Craniotomy Infection.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Limit of Detection; Meropenem; Reproducibility of Results; Tandem Mass Spectrometry; Valproic Acid; Vancomycin | 2023 |
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.
Topics: Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Fosfomycin; Humans; Meropenem; Vancomycin | 2023 |
The role and influence of bacteria on the growth of Blastocystis sp. subtype 3.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blastocystis; Blastocystis Infections; Feces; Humans; Meropenem; Vancomycin | 2023 |
A UHPLC-MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application.
Topics: Chromatography, High Pressure Liquid; Humans; Meropenem; Methanol; Moxalactam; Tandem Mass Spectrometry; Vancomycin | 2023 |
Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis.
Topics: Adult; Anti-Bacterial Agents; Humans; Meropenem; Probability; Renal Dialysis; Vancomycin | 2023 |
A case of Robinsoniella peoriensis bacteremia during using piperacillin-tazobactam.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Female; Fever; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2023 |
Periprosthetic joint infection:A South African perspective.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Cross-Sectional Studies; Gentamicins; Humans; Meropenem; Prosthesis-Related Infections; Reoperation; Retrospective Studies; South Africa; Vancomycin | 2023 |
International survey of antibiotic dosing and monitoring in adult intensive care units.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Vancomycin | 2023 |
Current Prevalence of Antimicrobial Resistance in Okayama from a National Database between 2018 and 2021.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin-Resistant Staphylococcus aureus; Prevalence; Vancomycin | 2023 |
Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users.
Topics: Adult; Anti-Bacterial Agents; Drug Users; Endocarditis; Endocarditis, Bacterial; Female; Humans; Meropenem; Serratia marcescens; Substance Abuse, Intravenous; Vancomycin | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |
Clinical features, management, and prognosis of Bacillus cereus sepsis in premature neonates.
Topics: Bacillus cereus; Child; China; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meropenem; Prognosis; Retrospective Studies; Sepsis; Vancomycin | 2023 |
Surveillance and analysis of bacterial resistance in a comprehensive teaching hospital from 2015 to 2017.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Hospitals, Teaching; Humans; Linezolid; Meropenem; Microbial Sensitivity Tests; Vancomycin | 2023 |
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Delivery of Health Care; Humans; Meningitis; Meropenem; Retrospective Studies; Staphylococcus; Vancomycin | 2023 |